Filter
1039
Filtered Results: 1039
Text search:
vascular
Featured
Recommendations
123
New Publications
246
Language
Document type
No document type
570
Guidelines
221
Studies & Reports
129
Manuals
52
Strategic & Response Plan
28
Fact sheets
19
Training Material
14
Brochures
3
Infographics
2
Situation Updates
1
Countries / Regions
India
86
Global
39
Brazil
27
Kenya
26
Indonesia
21
Philippines
20
South Africa
20
Senegal
19
Latin America and the Carribbean
19
Paraguay
17
Ethiopia
17
Burkina Faso
16
Western and Central Europe
16
Congo, Democratic Republic of
15
Haiti
13
Rwanda
12
Benin
11
Syria
11
Nigeria
11
Venezuela
11
Argentina
10
Mozambique
9
Africa
8
Bangladesh
8
Nepal
7
Colombia
7
Sierra Leone
7
Togo
7
Cameroon
7
Tanzania
7
Eastern Europe
7
Namibia
7
Ecuador
7
Madagascar
7
Ukraine
6
Ghana
6
Chile
6
Uganda
6
Lesotho
5
Malawi
5
Zimbabwe
5
Guinea
5
USA
5
Cambodia
5
Bolivia
5
Russia
5
Mali
5
Zambia
5
El Salvador
4
Niger
4
Germany
4
Côte d’Ivoire / Ivory Coast
4
Central African Republic
4
Angola
4
Liberia
4
Myanmar / Burma
4
Mexico
3
Asia
3
West and Central Africa
3
South–East Asia Region
3
North America
3
Botswana
3
Eswatini/ Swaziland
3
Canada
2
Morocco
2
Guinea-Bissau
2
France
2
Spain
2
East and Southern Africa
2
China
1
Albania
1
Congo-Brazzaville
1
Afghanistan
1
Burundi
1
Peru
1
Malaysia
1
Mongolia
1
Luxembourg
1
Jamaica
1
Belgium
1
United Kingdom
1
Portugal
1
Azerbaijan
1
Nicaragua
1
Djibouti
1
Yemen
1
Palestine
1
Honduras
1
Chad
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
473
Clinical Guidelines
175
Public Health
82
Women & Child Health
39
Key Resources
21
Capacity Building
17
Pharmacy & Technologies
4
Toolboxes
Mental Health
110
COVID-19
90
NCDs
75
Caregiver
40
Pharmacy
31
Rapid Response
30
Ebola
28
Conflict
26
TB
24
NTDs
24
AMR
24
Planetary Health
23
Disability
18
HIV
17
Refugee
8
Global Health Education
8
Specific Hazards
6
Natural Hazards
3
Cholera
3
Zika
3
Polio
1
The mounting burden of type 2 diabetes is a major concern in healthcare systems worldwide. The purpose of this study is to investigate the trend of type 2 diabetes from 1990 to 2019 in Asia.
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
The Resolution Population and Individual Approaches to the Prevention and Management of Diabetes and Obesity was approved by the 48th Directing Council of the Pan American Health Organization, September 29- October 3, 2008, in response to the epidemic of obesity and diabetes currently affecting the ...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NE...
Objective: To identify gaps in national stroke guidelines that could be bridged to enhance the quality of stroke care services in low- and
middle-income countries.
Methods: We systematically searched medical databases and websites of medical societies and contacted international organizations.
Co...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
